[Intense Pulsed Light (IPL) As A therapeutic Option for Meibomian Gland Dysfunction]
Overview
Authors
Affiliations
Meibomian gland dysfunction (MGD) is a common cause of dry eye disease. Intense pulsed light (IPL) treatment is a new and approved therapeutic option for MGD. The treatment consists of 2-4 sessions where light impulses are applied to the lower lid and temporal lid margin. The IPL technique is a safe form of treatment when the required safety precautions are followed. Current studies document an improvement of patients' subjective symptoms and objectively measured clinical parameters.
Iradier M, Del Buey M, Peris-Martinez C, Cedano P, Pinero D J Clin Med. 2021; 10(16).
PMID: 34441869 PMC: 8396809. DOI: 10.3390/jcm10163573.
Di Marino M, Conigliaro P, Aiello F, Valeri C, Giannini C, Mancino R J Ophthalmol. 2021; 2021:2023246.
PMID: 34221491 PMC: 8213457. DOI: 10.1155/2021/2023246.
Liu S, Tang S, Dong H, Huang X Exp Ther Med. 2020; 20(2):1815-1821.
PMID: 32765683 PMC: 7388499. DOI: 10.3892/etm.2020.8838.
Use of Intense Pulsed Light to Mitigate Meibomian Gland Dysfunction for Dry Eye Disease.
Suwal A, Hao J, Zhou D, Liu X, Suwal R, Lu C Int J Med Sci. 2020; 17(10):1385-1392.
PMID: 32624695 PMC: 7330664. DOI: 10.7150/ijms.44288.
Wei S, Ren X, Wang Y, Chou Y, Li X J Ophthalmol. 2020; 2020:3684963.
PMID: 32351719 PMC: 7174928. DOI: 10.1155/2020/3684963.